Quantamental Technologies LLC Mirati Therapeutics, Inc. Transaction History

Quantamental Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $267,911 - $397,834	7,332 New	7,332 $272,000
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $278,075 - $629,929	7,101 New	7,101 $477,000
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $112,820 - $224,643	-1,488 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $196,430 - $283,151	1,488 New	1,488 $218,000
Q3 2020 Nov 16, 2020	SELL	$113.26 - $167.27 $289,719 - $427,876	-2,558 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $184,201 - $307,957	2,558 New	2,558 $292,000
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $6,651 - $12,112	-94 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$77.91 - $109.6 $37,630 - $52,936	-483 Reduced 83.71%	94 $7,000
Q2 2019 Aug 12, 2019	BUY	$59.49 - $104.71 $34,325 - $60,417	577 New	577 $59,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.